[1]
2018. Early Phase I Results for 4-Demethyl-4-cholesteryloxypenclo-medine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies . Journal of Cancer Research Updates. 7, 3 (Aug. 2018), 75–78. DOI:https://doi.org/10.6000/1929-2279.2018.07.03.2.